BioWorld

June 12, 2003

No-Needle, Inhalable, Mice-Tested Flu Vaccine On Front Burner, Says Wistar; Would Skip Yearly Updates

NPS Planning To Sell $125M In Notes After Merger Talks End

Guilford Aims To Raise $50M Through Sale Of Convertibles

Other News To Note

Appointments And Advancements

Curis, Genentech Sign Potential $240M Hedgehog Pathway Deal

Restructuring companies are sometimes seen as foundering entities and a reduction in head count can be viewed as a red flag or a sign of trouble within. (BioWorld Today) Read More

Vertex Cutting 111 Employees, Increasing Focus On Pipeline

Today's news in brief

BioWorld

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...